13 NASDAQ Stocks with Highest Dividends
In recent years, technology markets have drawn more attention from investors around the world, especially those linked to the NASDAQ Composite Index.
Gilead Sciences Inc. (GILD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 8,390 | $1,169,314 | -12% | 0.59% |
| 2. | Ayrshire Capital Management John Nevin Jr. | 5,400 | $752,598 | 0.39% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.92 | 10,000 | $999,150.00 | 88,173 | 2015-02-06 | Filing | |
| $43.05 | 10,000 | $430,493.00 | 69,458 | 2013-02-28 | Filing | |
| $44.00 | 10,000 | $439,955.00 | 26,097 | 2012-02-22 | Filing | |
| $38.60 | 8,704 | $335,974.40 | 12,800 | 2010-05-04 | Filing | |
| $38.59 | 4,096 | $158,064.64 | 4,096 | 2010-05-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $136.82 | 10,000 | $1,368,162.00 | 642,567 | 2026-03-27 | Filing | |
| $144.23 | 3,000 | $432,690.00 | 131,779 | 2026-03-16 | Filing | |
| $144.23 | 3,000 | $432,690.00 | 179,191 | 2026-03-16 | Filing | |
| $145.71 | 100 | $14,571.00 | 642,308 | 2026-02-27 | Filing | |
| $145.18 | 6,419 | $931,901.43 | 642,408 | 2026-02-27 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 861,023 | $120,000,813 | 1.86% | |
| 2. | 489,770 | $55,688,192 | 0.11% | |
| 3. | 337,894 | $47,092,287 | 0.31% | |
| 4. | 256,653 | $35,769,728 | 0.44% | |
| 5. | 162,826 | $22,683,748 | 0.34% |
News See All
8 Best Quality Stocks to Buy According to Hedge Funds
On April 9, Tom Lee of Fundstrat appeared on CNBC's 'Closing Bell' to suggest that the market has reached a bottom.
7 Most Profitable Value Stocks to Buy Right Now
On April 2, Kevin Mahn, Hennion & Walsh Asset Management president and chief investment officer, joined 'Squawk Box' on CNBC to discuss market reactions to developments in the Iran war.
15 Best Low Volatility Blue Chip Stocks to Buy Now
The S&P 500 has declined by over 3.5% in 2026 so far. According to an April 1 report by CNBC, investors were being urged to brace for more volatility.
Dividend Stock Portfolio for Income: 15 Stocks to Invest In
Growth often takes center stage in an investing strategy. Still, for many investors, income can matter just as much, sometimes even more.
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Gilead Sciences Inc. (NASDAQ:GILD) is one of Goldman Sachs top healthcare stocks. On March 10, Jefferies initiated coverage of Gilead Sciences Inc.
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
The healthcare sector, long seen as a laggard amid the artificial intelligence boom, is beginning to turn the corner.
Barclays Takes Neutral Stance on Gilead Sciences (GILD) Despite Strategic Refocus
On February 20, Barclays began coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with an Equal Weight rating. The firm set a $155 price target on the stock.
13 Best NASDAQ Dividend Stocks to Buy Now
In recent years, technology markets, especially those tracked by the NASDAQ Composite Index, have drawn growing attention from investors around the world.
What Do Analysts Have to Say About Gilead Sciences (GILD) Post Earnings?
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best immunotherapy stocks to buy according to hedge funds. Gilead Sciences, Inc.